WHO ICTRP trial
Evaluation of Magnetic Resonance Imaging for Effacacy of Transcatheter Aortic…
ChiCTR1900021101 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900021101 |
|---|---|
| Public title | Evaluation of Magnetic Resonance Imaging for Effacacy of Transcatheter Aortic Valve Implantation in the Treatment of Moderate/Severe Aortic Regurgitation |
| Scientific title | The prospective, Non-randomized Cohort, Single Center Clinical Study of Magnetic Resonance Imaging for Evaluation of Effacacy of Transcatheter Aortic Valve Implantation(TAVI) in the Treatment of Moderate/Severe Aortic Regurgitation |
| Primary sponsor | West China School of Medicine/West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | New Treatment Measure Clinical Study |
| Countries | China |
| Conditions | Aortic valve regurgitation |
| Interventions | 1:TAVI;2:SAVR |
| Registration date | Jan 28, 2019 |
| Target size | 1:21;2:21 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: